From companies created to work in best in today's new value-based healthcare system to precision medicine, data analytics and interoperability, you can count on a healthcare IT landscape that is always in flux, thanks to new approaches driven by entrepreneurs who are adept at shaking things up.
This gallery highlights some of the most promising new companies and the founders and CEOs who are making news in 2017. Healthcare IT News is keeping tabs on the most exciting and promising new ventures.
Check back often as we will be updating the collection regularly.
Conversa grabs $8M in initial funding
San Rafael, California-based Conversa Health, which describes itself as “healthcare’s conversation platform,” has raised $8 million in its first round of funding. The startup will use the funding to expand Conversa’s product capabilities and clinical conversation library, enhance its customer and distribution partner operations, and add to its team to meet the market’s growing demand, Conversa CEO and co-founder West Shell III said in a statement.
Redox, launched by three Epic System engineers in 2013, has received a $1 million add-on investment from the Intermountain Healthcare Innovation Fund, the commercialization arm of the Salt Lake City-based healthcare system.
Clinical Sensors draws $1.5M in NIH grants to boost its sepsis work
Clinical Sensors, a startup based in Research Triangle Park, North Carolina, has been awarded two Small Business Research Grants from the National Institutes of Health.
ClearDATA lands $12M to expand cloud services
As ClearDATA CEO Darin Brannan sees it: “The healthcare digital revolution is in full swing," and ClearDATA is well positioned with its HIPAA-compliant cloud.
Venture Forum winner Sansoro Health lands $5.2 million
Minneapolis-based startup Sansoro Health, which claims its tech makes it easy to exchange data in real-time between digital health applications and electronic health records, has landed $5.2 million in its first round of funding.
FDA reversal gives 23andMe clearance to sell generic tests direct to consumers.
The U.S. Food and Drug Administration announced April 6 that it would allow 23andMe to market its Personal Genome Service Genetic Health Risk tests straight to consumers, which could help them make more informed decisions about their lifestyles and healthcare. For the FDA, it's a reversal. For 23andMe CEO and Co-Founder Anne Wojcicki it might be seen as vindication.
Ivenix grabs $50 million to build next generation infusion pump
CEO Stuart Randle said the startup will use its first round of funding to enhance its technology platform and work toward FDA clearance.
Livongo Health founder and CEO Glen Tullman plans to go big with his startup.
The diabetes management startup launched by former Allscripts CEO Glen Tullman, has landed a $52.5 million round of funding. It could be a game-changer. The new funding not only helps the company grow its diabetes work, but also to take on the management of other chronic conditions – and expand into international markets.
Intermountain, Oxeon launch startup to cut variation in healthcare
Intermountain Healthcare and Oxeon, a healthcare growth services firm, have launched Empiric Health to take the variation out of healthcare. The founders describe Empiric as a technology-enabled service focused on addressing variation in both healthcare costs and healthcare outcomes.
Digital Health Solutions goes to market with software aimed at better assessing patient risks.
Digital Health Solutions, a startup launched by two Indiana University School of Medicine professionals, is commercializing software it said will help pediatricians better target care for their patients.
Bioinformatics company Omicia acquires Spiral Genetics
The acquisition is expected to enrich Omicia’s trademarked Opal clinical genomics software platform with Spiral’s secondary next-generation sequencing analysis and structural variant capabilities.
Aledade CEO Farzad Mostashari
Aledade, the startup former national coordinator Farzad Mostashari, MD, launched in June 2014 has raised $20 million in fundin this year, for a total of $55 million to date. Aledade plans to use the investment to expand its provider network and grow partnerships with commercial and Medicare Advantage health plans.
Sean Carroll, Arcadia Healthcare Solutions CEO
At the beginning of January 2017, Arcadia Healthcare Solutions landed $30 million in new capital from investors including the Merck Global Health Innovation Fund, GE Ventures and others. The cash infusion will help the data aggregation and analytics company innovate, CEO Sean Carroll said.
PeraHealth CEO Stephanie Alexander
PeraHealth, which develops predictive clinical surveillance technology in use at more than 80 hospitals across the country, secured $14 million from the equity firm Mainsail Partners, which will be put to work to build more clinical tools and expand the business.
In the fall of 2016, Welltok landed $33.7 million in unding and said it planned to use the investment to build out its CaféWell Health Optimization Platform, which curates and connects consumers with benefits, resources and rewards, and it provides personalized action plans for each individual.
Augmedix co-founders Ian Shakil and Pelu Tran
Augmedix, which has harnessed Google Glass technology to develop tools to improve physician workflow and productivity, announced at the end of 2016. The startup has secured a $23 million round of funding from new investors McKesson Ventures, OrbiMed and others.
Oncology startup Flatiron Health bolstering its OncologyCloud with $175M third round of funding
Cloud-based oncology software startup Flatiron Health’s Series C fundraising round led by pharmaceutical giant Roche about a year ago had some analysts speculating that an IPO might be in the offing for the New York City startup, founded by Nat Turner and Zach Weinberg in 2012. But, it looks like the company is staying the course – at least for now.